These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 5410397)

  • 1. Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa).
    McDowell F; Lee JE; Swift T; Sweet RD; Ogsbury JS; Kessler JT
    Ann Intern Med; 1970 Jan; 72(1):29-35. PubMed ID: 5410397
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinsonism-dementia of Guam: treatment with levodopa and L-alpha-methyldopahydrazine.
    Holden EM; Brody JA; Chase TN
    Neurology; 1974 Mar; 24(3):263-5. PubMed ID: 4855953
    [No Abstract]   [Full Text] [Related]  

  • 3. L-Dopa treatment in Parkinson's Disease.
    Rinne UK; Sonninen V; Siirtola T
    Eur Neurol; 1970; 4(6):348-69. PubMed ID: 4932969
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of Parkinson's syndrome with L-dopa].
    Kaeser HE; Ferel D; Wurmser P
    Schweiz Med Wochenschr; 1970 May; 100(19):805-13. PubMed ID: 4924276
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of Levodopa for Parkinsonism. Levodopa (Dopar, Larodopa).
    JAMA; 1971 Mar; 215(12):1969-72. PubMed ID: 4396120
    [No Abstract]   [Full Text] [Related]  

  • 6. The management of Parkinson's syndrome.
    Wanger SL
    Med Clin North Am; 1972 May; 56(3):693-709. PubMed ID: 4556201
    [No Abstract]   [Full Text] [Related]  

  • 7. Augmenting the action of levodopa.
    Rao SK; Vakil SD; Calne DB; Hilson A
    Postgrad Med J; 1972 Nov; 48(565):653-6. PubMed ID: 4568331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of gastric motility on levodopa.
    Fermaglich J; O'Doherty DS
    Dis Nerv Syst; 1972 Sep; 33(9):624-5. PubMed ID: 4649158
    [No Abstract]   [Full Text] [Related]  

  • 9. Levodopa for parkinsonism in elderly and demented patients.
    Broe GA; Caird FI
    Med J Aust; 1973 Mar; 1(13):630-5. PubMed ID: 4702182
    [No Abstract]   [Full Text] [Related]  

  • 10. Alpha-methyldopa as an adjunct to levodopa treatment of Parkinson's disease.
    Sweet RD; Lee JE; McDowell F
    Trans Am Neurol Assoc; 1971; 96():59-65. PubMed ID: 5159130
    [No Abstract]   [Full Text] [Related]  

  • 11. [Medical treatment of Parkinson's disease].
    Castaigne P; Rondot P; Ribadeau-Dumas JL
    Ann Med Interne (Paris); 1972 Apr; 123(4):357-64. PubMed ID: 5077040
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of Parkinson's disease with L-dopa].
    Guglielmi L; Vecchi L
    Clin Ter; 1970 May; 53(3):259-69. PubMed ID: 4917328
    [No Abstract]   [Full Text] [Related]  

  • 13. Levodopa (Larodopa). For the relief of symptoms associated with Parkinson's disease and syndrome.
    Clin Pharmacol Ther; 1970; 11(6):921-4. PubMed ID: 4921295
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].
    Ferel D
    Schweiz Med Wochenschr; 1972 Jan; 102(3):88-94. PubMed ID: 4551909
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor].
    Lombardo L; de la Garza R; Ivan-Reynoso G
    Arch Invest Med (Mex); 1974; 5(2):105-16. PubMed ID: 4433198
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic uses and side effects of L-dopa.
    Boshes B
    Adv Intern Med; 1972; 18():219-49. PubMed ID: 4576081
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticholinergic withdrawal and benzhexol treatment in Parkinson's disease.
    Horrocks PM; Vicary DJ; Rees JE; Parkes JD; Marsden CD
    J Neurol Neurosurg Psychiatry; 1973 Dec; 36(6):936-41. PubMed ID: 4772727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of Parkinson's disease with levodopa].
    Sigwald J; Raymondeaud C; Grégoire J
    Therapeutique; 1972 Nov; 48(9):543-54. PubMed ID: 4650524
    [No Abstract]   [Full Text] [Related]  

  • 19. Reversal by levodopa of cholinergic hypersensitivity in Parkinson's disease.
    Weintraub MI; Van Woert MH
    N Engl J Med; 1971 Feb; 284(8):412-5. PubMed ID: 5540479
    [No Abstract]   [Full Text] [Related]  

  • 20. MK 486 and levodopa in treatment of Parkinsonism.
    Lieberman AN; Derby BM; Feigenson J; Goodgold A; Nesbitte J; Resurreccion EC; Valdivia F
    Dis Nerv Syst; 1973; 34(4):167-71. PubMed ID: 4711885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.